Announcements Trials
Browse Landscape

Status

Unknown 2Completed 2

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 15Observational 4

Sponsor

Cancer Type

Gynecologic 4

Conditions

Ovarian Neoplasms 4

Interventions

Surveys and Questionnaires 529Blood Specimen Collection 406Surgical Procedures, Operative 151Radiotherapy 131Interviews as Topic 131Drug Therapy 123Observation 122Magnetic Resonance Spectroscopy 104Biopsy 103Specimen Handling 70Data Collection 70Neoadjuvant Therapy 65Immunohistochemistry 64Magnetic Resonance Imaging 61Immune Checkpoint Inhibitors 59Watchful Waiting 52Immunotherapy 51Bevacizumab 50Positron Emission Tomography Computed Tomography 46Ultrasonography 44Hematologic Tests 42Liquid Biopsy 41Tomography, X-Ray Computed 40Therapeutics 40Radiosurgery 40Colonoscopy 40pembrolizumab 37Hepatectomy 37Gene Expression Profiling 36High-Energy Shock Waves 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Observational × 1-dodecylpyridoxal × Clear all
NCT05976932 2023-08-04

Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian Cancer

Fudan University

Unknown
20 enrolled
Gynecologic

Ovarian Neoplasms

NCT05868889 2023-05-24

Retrospective Multicenter Study of Elderly Patients With Ovarian Cancer Treated With Trabectedin and PLD

Grupo Español de Investigación en Cáncer de Ovario

Completed
43 enrolled
Gynecologic

Ovarian Neoplasms

NCT03562533 2019-02-28

Real-World Effectiveness of PLD in Platinum- Sensitive Recurrent Ovarian Cancer

Konkuk University Medical Center

Completed
432 enrolled
Gynecologic

Ovarian Neoplasms

NCT03446495 2018-02-26

Renaissance

Scientific Medical Society, Kazakhstan

Unknown
60 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡